Clinical role of positron emission tomography in oncology
Top Cited Papers
- 1 March 2001
- journal article
- review article
- Published by Elsevier in The Lancet Oncology
- Vol. 2 (3) , 157-164
- https://doi.org/10.1016/s1470-2045(00)00257-6
Abstract
No abstract availableKeywords
This publication has 42 references indexed in Scilit:
- Positron emission tomography and colorectal cancerBritish Journal of Surgery, 2001
- Relation between tumour response to first-line chemotherapy and survival in advanced colorectal cancer: a meta-analysisThe Lancet, 2000
- Modulation of fluorouracil tissue pharmacokinetics by eniluracil: in-vivo imaging of drug actionThe Lancet, 2000
- 33. Comparative study of sentinel lymph node imaging/biopsy and 18F-FDG PET in oral cancer stagingNuclear Medicine Communications, 2000
- New Guidelines to Evaluate the Response to Treatment in Solid TumorsJNCI Journal of the National Cancer Institute, 2000
- Measurement of clinical and subclinical tumour response using [18F]-fluorodeoxyglucose and positron emission tomography: review and 1999 EORTC recommendationsEuropean Journal Of Cancer, 1999
- Positron Emission Tomography with 18-Fluorodeoxyglucose in the Staging and Follow-up of Lymphoma in the ChestActa Oncologica, 1999
- The Role of FDG-PET in the Preoperative Assessment of N-Staging in Head and Neck CancerActa Oto-Laryngologica, 1996
- Contribution of PET in the diagnosis of recurrent colorectal cancer: comparison with conventional imagingEuropean Journal of Surgical Oncology, 1995
- How Cells Absorb GlucoseScientific American, 1992